Cell-based passive immunization for protection against SARS-CoV-2 infection
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell-based passive immunization for protection against SARS-CoV-2 infection
Authors
Keywords
-
Journal
Stem Cell Research & Therapy
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-07
DOI
10.1186/s13287-023-03556-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
- (2023) Pete Schmidt et al. Science Translational Medicine
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
- (2022) Sharifa Nasreen et al. Nature Microbiology
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
- (2022) Myron J. Levin et al. NEW ENGLAND JOURNAL OF MEDICINE
- An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo
- (2022) Nariko Ikemura et al. Science Translational Medicine
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
- (2022) Kathryn Westendorf et al. Cell Reports
- Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
- (2022) Shane Miersch et al. Cell Reports
- Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors
- (2022) Amanda M. Nash et al. Science Advances
- Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
- (2022) Tiphaine Goulenok et al. Lancet Rheumatology
- Peptide–Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants
- (2022) Jonathan M. Labriola et al. ACS Chemical Biology
- Tixagevimab/cilgavimab pre‐exposure prophylaxis is associated with lower breakthrough infection risk in vaccinated solid organ transplant recipients during the omicron wave
- (2022) Ayman Al Jurdi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
- (2022) Aekkachai Tuekprakhon et al. CELL
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
- (2022) Qian Wang et al. NATURE
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
- (2022) Erin M. Scherer et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Antibody from Single Human V H -rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion
- (2022) Sai Luo et al. Science Immunology
- Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
- (2022) Abigael E. Chaouat et al. iScience
- Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
- (2022) Panke Qu et al. Cell Host & Microbe
- Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
- (2022) Cherrelle Dacon et al. Cell Host & Microbe
- Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
- (2021) C. Garrett Rappazzo et al. SCIENCE
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
- (2021) Ayelet Grupper et al. Clinical Journal of the American Society of Nephrology
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
- (2021) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
- (2021) Bryan E. Jones et al. Science Translational Medicine
- Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells
- (2021) Bo Wang et al. Nature Biomedical Engineering
- First in Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients with COVID‐19
- (2021) Peter Chen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Population pharmacokinetics and pharmacodynamics of the neutralizing antibodies bamlanivimab and etesevimab in patients with mild to moderate COVID‐19 infection
- (2021) Emmanuel Chigutsa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Antibody titers and protection against a SARS-CoV-2 infection
- (2021) Chloé Dimeglio et al. JOURNAL OF INFECTION
- Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations
- (2021) Shane Miersch et al. JOURNAL OF MOLECULAR BIOLOGY
- Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients
- (2021) Ilies Benotmane et al. KIDNEY INTERNATIONAL
- Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
- (2021) Michael Dougan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel
- (2021) Tamara Pilishvili et al. NEW ENGLAND JOURNAL OF MEDICINE
- Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
- (2021) Meagan P. O’Brien et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice
- (2021) Tobias Deuse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail
- (2021) Arnaud C. Drouin et al. Viruses-Basel
- A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants
- (2021) Yanyun Du et al. Nature Communications
- Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2
- (2021) Yusuke Higuchi et al. Nature Communications
- Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
- (2021) Mounzer E Agha et al. Open Forum Infectious Diseases
- A Quantitative Modeling and Simulation Framework to Support Candidate and Dose Selection of Anti‐SARS‐CoV‐2 Monoclonal Antibodies to Advance Bamlanivimab Into a First‐in‐Human Clinical Trial
- (2021) Emmanuel Chigutsa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- (2021) Sara Y Tartof et al. LANCET
- Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
- (2021) Anil Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
- (2021) Maximilian J. Mair et al. JAMA Oncology
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
- (2020) Anum Glasgow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients
- (2019) Tobias Deuse et al. NATURE BIOTECHNOLOGY
- Trial of Embryonic Stem Cell–Derived Cardiac Progenitor Cells
- (2018) Leslie W. Miller JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Linking a cell-division gene and a suicide gene to define and improve cell therapy safety
- (2018) Qin Liang et al. NATURE
- Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
- (2017) Michiko Mandai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies
- (2015) Steven D Schwartz et al. LANCET
- Mesenchymal Stem Cells from Human Fat Engineered to Secrete BMP4 Are Nononcogenic, Suppress Brain Cancer, and Prolong Survival
- (2014) Q. Li et al. CLINICAL CANCER RESEARCH
- Retinal pigment epithelium development, plasticity, and tissue homeostasis
- (2013) Sabine Fuhrmann et al. EXPERIMENTAL EYE RESEARCH
- Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer’s Disease
- (2012) Maria Eriksdotter-Jönhagen et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Efficient Generation of Germ Line Transmitting Chimeras from C57BL/6N ES Cells by Aggregation with Outbred Host Embryos
- (2010) Marina Gertsenstein et al. PLoS One
- Dynamics of fat cell turnover in humans
- (2008) Kirsty L. Spalding et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started